These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs? Ferrari R, Cinca J, Marber M. Eur Heart J; 1999 Mar 28; 20(6):397-8. PubMed ID: 10213339 [No Abstract] [Full Text] [Related]
29. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P. Ital Heart J Suppl; 2002 Mar 28; 3(3):337-43. PubMed ID: 12040849 [Abstract] [Full Text] [Related]
30. Acute therapy of maternal and fetal arrhythmias during pregnancy. Trappe HJ. J Intensive Care Med; 2006 Mar 28; 21(5):305-15. PubMed ID: 16946446 [Abstract] [Full Text] [Related]
36. Philosophy of antiarrhythmic approaches to ventricular tachyarrhythmias close to the 21st century. Breithardt G, Haverkamp W, Böcker D, Borggrefe M. Rev Port Cardiol; 1998 Dec 28; 17(12):981-91. PubMed ID: 9973859 [Abstract] [Full Text] [Related]
37. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)]. Manz M, Mletzko R, Jung W, Lüderitz B. Herz; 1990 Apr 28; 15(2):79-89. PubMed ID: 2188894 [Abstract] [Full Text] [Related]
38. [Ventricular cardiac arrhythmias 1992. Summary and perspectives]. Breithardt G, Borggrefe M. Z Kardiol; 1992 Apr 28; 81 Suppl 4():163-5. PubMed ID: 1290293 [Abstract] [Full Text] [Related]